MedImmune pulls 13 lots of H1N1 vaccine with decreased potency

12/22/2009 | Los Angeles Times (tiered subscription model)

MedImmune is recalling 4.7 million doses of its intranasal H1N1 flu vaccine that lost potency after shipment. The recall is not related to safety problems, the FDA said, and the 13 batches "passed pre-release testing for safety, purity and potency." Sanofi-Aventis announced a similar recall last week for its H1N1 vaccine for children.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA